U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH NIH News National Institute of Allergy and Infectious Diseases (NIAID) http://www3.niaid.nih.gov/ FOR IMMEDIATE RELEASE: Tuesday, March 21, 2006 CONTACT: Anne A. Oplinger, 301-402-1663, aoplinger@xxxxxxxxxxxxx News Advisory NIAID UPDATES "FOCUS ON TB" WEB FEATURE The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has updated "Focus on Tuberculosis (TB)" in advance of World TB Day, March 24. This Web feature describes TB research being done in NIAID's labs in Bethesda, MD, and by NIAID-supported scientists across the country and around the world. Every second of every day, someone is newly infected by Mycobacterium tuberculosis, the bacterium that causes TB. The ancient affliction still reigns as one of the world's leading killers. Yet, there is reason for hope. Visit the Web site to read about research studies in progress such as these: -- Improving a Tried and True Vaccine -- BCG for the 21st Century http://www3.niaid.nih.gov/news/focuson/tb/research/preventing/horwitz_rB CG_vaccine.htm (Note: For some users, this link will be inactive due to email formatting properties. To view another version of this link, please see http://www.nih.gov/news/pr/mar2006/niaid-21a.htm) An NIAID grantee is using genetic engineering to improve BCG, a century-old TB vaccine. He is working on a better TB vaccine for infants; a "booster" shot for the four billion people worldwide who've previously received BCG vaccine; and a vaccine that will be safe for people with weakened immune systems. -- U.S.-South Korean Collaboration Will Advance TB Care http://www3.niaid.nih.gov/news/focuson/tb/research/global/us_korea_colla boration.htm (Note: For some users, this link will be inactive due to email formatting properties. To view another version of this link, please see http://www.nih.gov/news/pr/mar2006/niaid-21a.htm) The National TB Hospital in Masan, South Korea, admits more than 500 patients a year with multidrug-resistant TB (MDR-TB). NIAID scientists have joined with researcher-clinicians at the hospital to improve imaging technology and other techniques that will speed diagnostics and new treatments for the often-fatal MDR-TB. For these and other story ideas, visit the "Focus on TB" Web site at http://www3.niaid.nih.gov/news/focuson/tb/default.htm. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov. NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. The National Institutes of Health (NIH) -- "The Nation's Medical Research Agency" -- includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov. ## This NIH News Release is available online at: http://www.nih.gov/news/pr/mar2006/niaid-21a.htm. To subscribe (or unsubscribe) from this list, go to http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.
